144 filed Jun 25, 2026 at 17:29 ET
Atlas Venture Opportunity Fund I, L.P., a venture capital affiliate, filed a Form 144 indicating intent to sell 5,019 shares of Dyne Therapeutics (DYN) common stock, with an estimated value of approximately $102,036. The shares were acquired via private placement in August 2020. The proposed sale is negligible relative to DYN's $3.6B market cap and appears routine portfolio management by a significant early investor.